Old Web
English
Sign In
Acemap
>
Paper
>
PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach
PD-0849 Concomitant Nivolumab and RT in metastatic kidney cancer. Benefit of ablative vs palliative approach
2021
Giulio Francolini
V. Di Cataldo
Beatrice Detti
Mauro Loi
Paolo Ghirardelli
V. Vavassori
Luca Nicosia
F. Alongi
Luca Triggiani
S. La Mattina
Andrea Gaetano Allegra
E. Scoccimarro
M. Aquilano
S. Lucidi
M. Valzano
A. Peruzzi
I. Morelli
M. Mariotti
V. Salvestrini
G. Stocchi
L.P. Ciccone
Isacco Desideri
Lorenzo Livi
Keywords:
Concomitant
Ablative case
Oncology
Metastatic kidney cancer
Nivolumab
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]